1/17/2022China NMPA Novel Drug Approvals 2021 (PharmCube)

1/17/2022Licensing Moves Towards Early-Stage Assets in 2021: PharmaDJ

1/17/2022Massive Series A Rounds in December 2021 Highlight New R&D Trends: Pha...

1/14/2022Recent Executive Moves

1/14/2022NMPA Announces Package Insert Revision of Cimetidine Injectable Formul...

1/13/2022CDE Issues Two Technical Guidance Documents for Clinical Trials of Art...

1/13/2022FUJIFILM Irvine Scientific Plans Bioprocessing Center in China

1/13/2022Gracell Biotechnologies Sets Up Innovation Center in U.S.

1/13/2022China Invests in Building Biotech (PharmExec)

1/12/2022Fosun and Insilico Announce a Strategic, AI-driven Drug Discovery and ...

1/12/2022BioNTech Remains Committed to Seeking China Approval for COVID-19 Vacc...

1/11/2022NMPA Issues the List of Reference Formulations for GQCE Studies (50th ...

1/11/2022Junshi and Coherus Expand I/O Collaboration to Include TIGIT-Targeted ...

1/11/2022Sana Biotech, IASO Bio and Innovent Announce Non-Exclusive License Dea...

1/11/2022Reuters: Biotech Is Set for a Geopolitical Stress Test

1/11/2022China Healthcare Stocks Post Worst Start in Six Years as Woes Deepen (...

1/11/2022Beijing IP Court Issues "Reference for Case Filing in Civil Cases Invo...

1/11/2022China Solidifies Drug-Buying Programme That Saved $55 Billion

1/10/2022CDE Issues the Technical Guidelines for Clinical Trials of New Anti-Ra...

1/9/20222021 Wraps Up with Multi-billion Dollar Deals: PharmaDJ

1/7/2022Junshi and DotBio to Co-develop Next-Gen Antibody Therapy with DotBody...

1/7/2022Nuance Pharma Acquires Sino Health to Strengthen Commercial Capabiliti...

1/7/2022CDE Issues the Technical Guidance for Research of New TCM Toxicology S...

1/7/2022CDE Issues the Technical Guidance for Non-Clinical Drug Dependence Res...

1/7/2022CDE Issues the Technical Guidance for Clinical Pharmacokinetic Study o...

1/7/2022CDE Issues the Technical Guidance for Human Bioavailability and Bioequ...

1/7/2022CDE Issues the Guidance Principles for Random Allocation of Drug Clini...

1/7/2022NMPA Approves MSD's Letermovir and Eli Lilly's Abemaciclib in China

1/7/2022Drug R&D and Product Registration News Digest January 2022 (1)

1/7/2022Recent Executive Moves

Page:97/719 Total number of articles:21546: [First][<<] [95] [96] [97] [98] [99] [>>] [End]